Retinal Degeneration - Potsdam Meeting der ProRetina Stiftung 2018
Yet another Push for Treatment
Friday, April 13, 2018
13:00-13:05 Welcome remarks, Franz Badura
13:05-14:30 Session 1 – Selected Poster Presentations
14:30-15:00 Keynote Lecture
Hendrik Scholl, Basel
“Cutting edge advances in the treatment of retinal degeneration”
15:00-15:45 Coffee break
15:45-17:25 Session 2 – New light on the retinal pigment epithelium (RPE)
15:45-16:10 Patric Turowski, London
“Regulation of RPE function by ARMCX proteins”
16:10-16:35 Catherine Bowes, Rickman Durham
“Ocular Exosomes as Diagnostic and Prognostic Indicators for AMD”
16:35-17:00 Emeline F. Nandrot, Paris
”Circadian phagocytosis of outer segments by RPE cells in health and disease: more complexity than meets the eye”
17:00-17:25 Clare E. Futter, London
”Modelling lysosome dysfunction in the retinal pigment epithelium in early AMD**”**
17:30 Dinner
19:00-20:00 Evening Lecture: Alexander Wilke, Huglfing, „Pharmaceutical research yesterday, today and…?“
20:00-open Swingin’ Poster Session
Saturday, April 14, 2018
09:00-10:40 Session 4 – Gene therapy and retinal degeneration
09:00-09:25 Bernd Wissinger on behalf of the RD-CURE Consortium, Tübingen
**„**First Supplementary Gene Therapy for CNGA3-linked Achromatopsia”
09:25-09:50 Alun Barnard, Oxford
“Development and current status of gene therapy for choroideremia”
09:50-10:15 Kerstin Nagel-Wolfrum, Mainz
“Usher-Syndrome read-through therapy”
10:15-10:40 Antoine Chaffiol, Paris
„A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina”
10:40-11:15 Coffee break
11:15-12:55 Session 5 – Targeting early and late AMD
11:15-11:40 Iris Heid, Regensburg
“Understanding the progression from early to late AMD”
11:40-12:05 Horst Helbig, Regensburg
“Treating neovascular AMD by blocking VEGF – Experiences”
Oliver Zeitz, Berlin
“Treating neovascular AMD by blocking VEGF – Prospects”
12:05-12:30 Steffen Schmitz-Valckenberg, Bonn
„Atrophic AMD – outcome measurements“
12:30-12:55 Cedric Francois, Cambridge, USA
“Targeting atrophic AMD via the complement system – Complement factor 3”
12:55-13:00 Concluding remarks
13:00 Lunch and end of meeting